Dr. Jian Zeng

Cardiothoracic Surgery

Chief Physician, Professor, Master's Supervisor, Deputy Director, Pulmonary Surgery Department, Zhejiang Cancer Hospital, China

China

Publications Featured in

Publications

Selected publications from PubMed

Author Correction: Multi-omics profiling reveals tumor microenvironment characteristics linked to immunotherapy response and prognosis in non-small cell lung cancer.

Zhang L, Zeng J, Wen J, Yang Z, Tian Z, Zhang M, Zhang X, Zheng B, Lin Y, Lai F

NPJ Precis Oncol. 2026 Jun 4;10(1) doi: 10.1038/s41698-026-01540-9.

Multi-omics profiling reveals tumor microenvironment characteristics linked to immunotherapy response and prognosis in non-small cell lung cancer.

Zhang L, Zeng J, Wen J, Yang Z, Tian Z, Zhang M, Zhang X, Zheng B, Lin Y, Lai F

NPJ Precis Oncol. 2026 May 11;10(1) doi: 10.1038/s41698-026-01474-2.

Sesquiterpenoids from the flower of Chrysanthemum indicum L. and their anti-lung cancer cytotoxic activity.

You Y, Ren C, Wang C, Shi J, Wang C, Huang Q, Zhao D, Zeng J

Nat Prod Res. 2026 May 4;:1-5 doi: 10.1080/14786419.2026.2665765.

Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality Registry.

Stirling RG, Tissera S, Zeng J, Lloyd M, Krishnaprasad K, Briggs L, Lesage J, Wood T, Underhill C, Parakh S, Irving L, Faisal W, Blum R, Richardson G, Parente P, Caldecott M, Olesen I, Torres J, Samuel E, Lyne C, See K, Langton D, John T, Wright GM, Conron M, Bartlett J, Atkin N, Moore M, Adabi G, Clegg L, Zeps N, Harden S, McQuilten Z, Zalcberg J

JTO Clin Res Rep. 2026 May;7(5):100984 doi: 10.1016/j.jtocrr.2026.100984.

PSMD11 facilitates immune escape by recruiting USP14 to modulate the deubiquitinating degradation of PD-L1 in non-small cell lung cancer.

Xi Y, Yang P, Zeng J, Zhou Y, Patel AJ, Shen W, Liu X, Rajandram R, Krishnasamy S

J Thorac Dis. 2025 Sep 30;17(9):7212-7224 doi: 10.21037/jtd-2025-1672.

Featured in

1h 21min

Enhancing Thoracic Cancer Management

Since the late 20th century, Chinese medicine has developed rapidly in comparison to the rest of the world, being China one of the countries which have made more significant advances in medical research and treatments. Aiming to provide a comprehensive, in-depth look at how Chinese medicine is practiced and examine its impact on global health, we proudly introduce Meet the Institutions, as part of the Healing in China series, which gives you access to the best centers of excellence in China, and the opportunity to collaborate with these hospitals and participate in activities and projects organized by them. In this event, AIS Channel specially invites top thoracic surgery experts from China and Italy to share academic insights on enhancing thoracic cancer management. This event features medical presentations, operation videos, and interactive discussions to enhance surgical skills and improve global standards in this field.

With Johnson & Johnson MedTech

Published

Dec 2023

Share this expert

Help your network discover Dr. Jian Zeng's clinical expertise.